Supreme Court Calls For Solicitor’s Views In Biologic Patent Case
WASHINGTON, D.C. — The U.S. Supreme Court on June 20 invited the government to weigh in on a Federal Circuit U.S. Court of Appeals’ ruling that biosimilar makers must wait until...To view the full article, register now.
Already a subscriber? Click here to view full article